Navigation Links
Safety to the Power of Three: B. Braun Medical Inc. Announces Introcan Safety® 3 Closed IV Catheter
Date:10/19/2011

BETHLEHEM, Pa., Oct. 19, 2011 /PRNewswire/ -- Expanding its offering of passive safety devices to protect both clinicians and patients from needlestick injuries (NSIs), B. Braun Medical Inc. (B. Braun) recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance of the company's Introcan Safety® 3 Closed IV Catheter, the next generation of B. Braun's Introcan Safety® IV Catheter. B. Braun made the announcement during the Association for Vascular Access 2011 Annual Scientific Meeting in San Jose, Calif., in early October.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

"Recent research(1) confirms passive safety engineered devices are most effective for needlestick injury prevention," said Tom Sutton, Vice President, Vascular Access and IV Systems for B. Braun Medical Inc. "The Introcan Safety® 3 is designed to provide clinicians with not only an effective passive needlestick safety device, but also an added layer of safety and control with a bidirectional blood control valve to aid in the prevention of blood exposure each time the device is accessed."

The Introcan Safety® 3 features all elements of B. Braun's existing and proven Introcan Safety® IV Catheter. From insertion to advancing the catheter to needle removal, the Introcan Safety® 3 is designed to help protect clinicians and patients from NSIs as the device cannot be bypassed or activated inadvertently.

B. Braun's Introcan Safety® 3 will provide protection through:

  • Passive Safety Needle Shield to aid in the prevention of NSIs
  • Multiple Access Blood Control Valve to aid in the prevention of blood exposure
  • Integrated Stabilization Platform to improve catheter stability and minimize movement within the vessel

For more information, please visit: Introcan Safety® 3 Closed IV Catheter, www.introcansafety.bbraunusa.com, or call 800-227-2862.    

(1) Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux), and published by Infection Control and Hospital Epidemiology, April 2010; 31:402-407

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. USC School of Pharmacy to Double Presence in Safety-net Clinics
2. Varian Medical Systems Publishes First Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
3. White House Drug Policy Director and Mothers Against Drunk Driving Unite to Combat Drugged Driving; Call on Parents to Act to Reduce Significant Public Safety Threat
4. FDA CONSUMER HEALTH INFORMATION - FDAs MedWatch Safety Alerts: September 2011
5. 1-800-GET-THIN - Lap-Band Safety and You
6. The Educational Review Systems First Annual Pediatric Medication Safety Summit
7. FDA CONSUMER HEALTH INFORMATION -- Foreign Exporters Study Food Safety Law
8. SurgiCount Medical Announces Agreement with 130+ Hospital Operator to Implement the Safety-Sponge® System
9. FDA Issues Safety Communication Regarding Increased Risk of Blood Clots with Certain Birth Control Pills
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Clinical Data Demonstrates Long-Term Safety of Boston Scientifics Alair[TM]Bronchial Thermoplasty System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... , April 27, 2016 Transparency ... "Skincare Devices Market - Global Industry Analysis, Size, Share, ... the report, the global skincare devices market was valued ... to expand at a CAGR of 10.1% from 2015 ... Browse the full Skincare Devices Market (Treatment Device ...
(Date:4/27/2016)... Kan. , April 27, 2016  Bayer ... , a senior from the University of Florida ... of the Bayer Excellence in Communication Award (BECA). ... schools, which were awarded a total of $70,000 ... the last four years, Bayer has provided a ...
(Date:4/27/2016)... April 27, 2016 Oasmia ... developer of a new generation of drugs within ... survival results for Paclical/Apealea in the Phase III ... with epithelial ovarian cancer. These preliminary results showed ... combination with carboplatin versus Taxol in combination with ...
Breaking Medicine Technology:
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine named Herr ... field of biomechatronics, technology that marries human physiology with electromechanics. He continues that work ... also the Founder of BionX , a leader in the field of prosthetic ...
(Date:4/28/2016)... ... April 28, 2016 , ... One way to ignore solid evidence is ... true. But we toss the baby out with the bathwater when we ignore all ... identifying higher-quality studies and otherwise making better use of education policy research. , “When ...
(Date:4/28/2016)... ... April 28, 2016 , ... Anzu®, ... announced a new Residency Education & Collaboration Platform for hospitals and medical ... and a host of collaboration tools designed to improve patient outcomes through ...
(Date:4/28/2016)... ... April 28, 2016 , ... Accreditation Commission for Health Care ... (COPA) to develop a comprehensive Specialty Pharmacy Accreditation with Distinction in Oncology. This ... ACHC provides a wide range of pharmacy accreditation services that assess the business ...
(Date:4/28/2016)... MO (PRWEB) , ... April 28, 2016 , ... Denise McCormick Baich had written poetry ... 2009 the poetry arrived again much like a tsunami and took on a more spiritual ... to her encouraged her to do more with it than just file it away. Friends ...
Breaking Medicine News(10 mins):